We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
The current CPMD market cap is 3.38M. The company's latest EPS is USD -0.0252 and P/E is -0.40.
| Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -954k | -8.91M | -14.49M | -2.99M | -5.21M |
| Net Income | -3.09M | -20.45M | -19.89M | -8.83M | -8.53M |
| Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 10.1M | 16.02M | 8.75M | 114k | 5.41M |
| Total Liabilities | 10.38M | 11.16M | 17.55M | 13.04M | 22.76M |
| Total Equity | -286k | 4.85M | -8.8M | -12.93M | -17.34M |
| Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -941k | -3.8M | -564k | -2.41M | -1.45M |
| Investing | -727k | -47k | N/A | 494k | -116k |
| Financing | 2.13M | 3.27M | 825k | 1.34M | 1.41M |
| Market Cap | 3.38M |
| Price to Earnings Ratio | -0.40 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 0 |
| Price to Book Ratio | -0.19 |
| Dividend Yield | - |
| Shares Outstanding | 337.96M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 942.73k |
| 52 Week Change | -0.99% |
| 52 Week High | 0.0279 |
| 52 Week Low | 0.000001 |
| Spread (Intraday) | 0 (0%) |
| Company Name | Cannapharmarx Inc (CE) |
| Address |
3411 silverside road,tatnall building wilmington, delaware 19810 |
| Website | https://www.cannapharmarx.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
